Biology of Blood and Marrow Transplantation · 2015 · 315 citations · 117 references
MedicinePathologyHistologyHistopathologyRenal PathologyGraft-versus-host DiseaseHepatic PathologyHepatobiliary PathologyLiver DiseaseTransplant PathologyGraft-versus-host Disease BiomarkersGraft-versus-host Disease GradingGraft-versus-host Disease PathophysiologyHistopathological GradingHistopathological InterpretationHistopathological LesionsHistopathology Of Liver DiseaseTransplant Biopsy Interpretation
Histopathological criteria for diagnosing acute and chronic GVHD were first outlined by the 2005 NIH Consensus Conference, but challenges remain in defining the threshold of histological changes needed for diagnostic certainty. The study aims to guide the use of biopsy data in prospective GVHD clinical trials, focusing on biomarker validation. The authors provide guidance on incorporating biopsy information into prospective clinical studies of GVHD. The 2014 Consensus updated histopathological criteria, expanding organ coverage and simplifying diagnostic categories from four to three—no GVHD, possible GVHD, and likely GVHD—to enhance reproducibility.
The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus-host disease (GVHD). The 2014 Consensus Conference led to this updated document with new information from histopathological studies of GVHD in the gut, liver, skin, and oral mucosa and an expanded discussion of GVHD in the lungs and kidneys. The recommendations for final histological diagnostic categories have been simplified from 4 categories to 3: no GVHD, possible GVHD, and likely GVHD, based on better reproducibility achieved by combining the previous categories of "consistent with GVHD" and "definite GVHD" into the single category of "likely GVHD." Issues remain in the histopathological characterization of GVHD, particularly with respect to the threshold of histological changes required for diagnostic certainty. Guidance is provided for the incorporation of biopsy information into prospective clinical studies of GVHD, particularly with respect to biomarker validation.
117
Madan Jagasia, Hildegard Greinix, Mukta Arora et al. · Biology of Blood and Marrow Transplantation · 2014 · 5.4K citations · Full text
Alexandra H. Filipovich, Daniel J. Weisdorf, Steven Z. Pavletic et al. · Biology of Blood and Marrow Transplantation · 2005 · 3.5K citations
Chronic graft-versus-host syndrome in man
Howard M. Shulman, Keith M. Sullivan, Paul L. Weiden et al. · The American Journal of Medicine · 1980 · 2.4K citations
Life Sciences, Immunology, Surgery +10
Mary E.D. Flowers, Yoshihiro Inamoto, Paul A. Carpenter et al. · Blood · 2011 · 681 citations · Full text